학술논문
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
Document Type
Article
Author
Source
In The Lancet Infectious Diseases June 2017 17(6):626-635
Subject
Language
ISSN
1473-3099